Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
HAO 
Haoxi Health Technology Limited Class A Ordinary Shares (HAO)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/01/2025: HAO (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -18.9% | Avg. Invested days 17 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 04/01/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 2.99M USD | Price to earnings Ratio 1.06 | 1Y Target Price - |
Price to earnings Ratio 1.06 | 1Y Target Price - | ||
Volume (30-day avg) 3198 | Beta 1.28 | 52 Weeks Range 1.04 - 265.00 | Updated Date 04/2/2025 |
52 Weeks Range 1.04 - 265.00 | Updated Date 04/2/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 1 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 2.66% | Operating Margin (TTM) 3.59% |
Management Effectiveness
Return on Assets (TTM) 10.75% | Return on Equity (TTM) 20.12% |
Valuation
Trailing PE 1.06 | Forward PE - | Enterprise Value -1878480 | Price to Sales(TTM) 0.06 |
Enterprise Value -1878480 | Price to Sales(TTM) 0.06 | ||
Enterprise Value to Revenue 0.63 | Enterprise Value to EBITDA 17.37 | Shares Outstanding 2131590 | Shares Floating 750805 |
Shares Outstanding 2131590 | Shares Floating 750805 | ||
Percent Insiders 21.79 | Percent Institutions 3.99 |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Haoxi Health Technology Limited Class A Ordinary Shares
Company Overview
History and Background
Haoxi Health Technology Limited focuses on telehealth and digital health solutions. It has evolved from its founding to offer comprehensive health management platforms.
Core Business Areas
- Telehealth Services: Provides remote medical consultations, diagnostics, and treatment plans through online platforms.
- Digital Health Platform: Offers a comprehensive platform for managing health records, tracking fitness, and accessing health information.
- E-pharmacy: Allows patients to order prescription and over-the-counter medications online.
Leadership and Structure
Details of Haoxi's leadership team and organizational structure are not publicly available.
Top Products and Market Share
Key Offerings
- Online Consultation Platform: Facilitates virtual doctor visits. Market share data is unavailable. Competitors include Teladoc Health (TDOC) and Amwell (AMWL).
- Health Data Management System: Enables patients to securely store and manage their health information. Market share data unavailable. Competitors include Epic Systems and Cerner.
- Online Pharmacy Services: Provides online prescription filling. Market share data unavailable. Competitors include CVS Health (CVS) and Walgreens Boots Alliance (WBA).
Market Dynamics
Industry Overview
The telehealth and digital health market is experiencing rapid growth, driven by increased demand for convenient and accessible healthcare solutions.
Positioning
Haoxi aims to establish itself as a leading provider of integrated digital health solutions, focusing on user-friendly interfaces and comprehensive services.
Total Addressable Market (TAM)
The global digital health market is projected to reach hundreds of billions of dollars. Haoxi is positioned to capture a portion of this TAM by focusing on specific segments.
Upturn SWOT Analysis
Strengths
- Innovative Technology
- Comprehensive service offerings
- Scalable platform
Weaknesses
- Limited Brand Recognition
- Dependence on Regulatory Approvals
- Data Security Concerns
Opportunities
- Expanding Telehealth Adoption
- Partnerships with Healthcare Providers
- Growing Demand for Personalized Medicine
Threats
- Increased Competition
- Evolving Regulatory Landscape
- Cybersecurity Breaches
Competitors and Market Share
Key Competitors
- TDOC
- AMWL
- CVS
- WBA
Competitive Landscape
Haoxi faces significant competition from established players. To succeed, Haoxi needs to differentiate itself through innovative technology, excellent customer service, and strategic partnerships.
Major Acquisitions
Growth Trajectory and Initiatives
Historical Growth: Historical growth trends cannot be determined without historical financial data.
Future Projections: Future growth projections are unavailable.
Recent Initiatives: Recent strategic initiatives are not readily available.
Summary
Haoxi Health Technology is a relatively new player in the competitive digital health market. Its strengths lie in its innovative technology and comprehensive service offerings. However, it faces challenges in brand recognition, regulatory hurdles, and competition from established players. Overcoming these challenges will be critical for its long-term success.
Similar Companies
AMWL
American Well Corp
AMWL
American Well Corp
TDOC
Teladoc Inc
TDOC
Teladoc Inc
Sources and Disclaimers
Data Sources:
- Publicly available information and market research reports.
Disclaimers:
This analysis is based on limited publicly available information and should not be considered financial advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Haoxi Health Technology Limited Class A Ordinary Shares
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2008-01-30 | Chairman & CEO Mr. Zhen Fan | ||
Sector Communication Services | Industry Advertising Agencies | Full time employees 30 | Website https://www.haoximedia.com |
Full time employees 30 | Website https://www.haoximedia.com | ||
Haoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China. The company offers online marketing solutions, including online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help advertisers acquire, convert, and retain consumers on various online media platforms. It places its ads through mainstream online short video and social media platforms, such as Toutiao, Douyin, WeChat, and Sina Weibo. The company serves advertiser client base primarily in the healthcare industry. Haoxi Health Technology Limited was founded in 2018 and is based in Chaoyang, China.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.